INTRODUCTION
T cell activation is a hallmark of chronic HIV infection (Hunt et al., 2016; Sereti and Altfeld, 2016) . T cells from HIV + patients express increased levels of activation markers, CD38 and HLA-DR, which predict more rapid progression to AIDS in advanced HIV infection (Balagopal et al., 2015; Giorgi et al., 1993; Karim et al., 2013; Langford et al., 2007) . Even with effective anti-retroviral therapy, T cell activation remains elevated in HIV-infected individuals, likely as a result of viral persistence (Hunt et al., 2016; Lorenzo-Redondo et al., 2016) . Lymphoid tissues are a major reservoir of HIV infection (Hufert et al., 1997; Kohler et al., 2016) . Viral infection leads to disrupted lymphoid architectures and altered cellular differentiation (Hong et al., 2016) . In particular, studies of human primary lymph nodes (LNs) from untreated HIV patients have revealed an expansion of follicular helper T (T FH ) cells (Lindqvist et al., 2012; Perreau et al., 2013) , which are classically identified by the expression of CXCR5, a chemokine receptor that enables proper follicular localization in the LN (Crotty, 2014; Haynes et al., 2007) . T FH cells are necessary for the development of affinity-matured broadly neutralizing antibody-producing B cells (Havenar-Daughton et al., 2017) . However, despite an increase in the abundance of T FH cells in the LN, protective antibody responses to vaccines are generally diminished in the setting of HIV infection (Crum-Cianflone et al., 2011; de Armas et al., 2017) . T FH cells from HIV + patients acquire a skewed functional phenotype and limited T cell receptor (TCR) diversity under persistent antigen stimulation . Functional assays performed in vitro also showed T FH cells from HIV-infected LNs were less effective at providing help to B cells .
Due to the importance of T FH cells in generating protective antibody responses, there have been substantial efforts to understand and manipulate T FH cells for better vaccine efficacy. By comparison, much less is known about other cell types in inflamed LNs. Because HIVdriven immune hyperactivation broadly impact T cells in lymphoid tissues (Biancotto et al., 2007) , we hypothesized that a more comprehensive understanding of the complexity of activated T cells in the lymphoid compartment could provide insights into dysregulated T:B cell interactions. Unique functional and phenotypic states identified in this setting may be harnessed for the improvement of efficacious protective antibody responses. In this study, we combined a number of high-dimensional and functional approaches to examine activated T cells in primary human LNs from HIV-infected individuals, with the goal of discovering T cell populations that contribute to abnormal responses in the lymphoid environment during chronic viral infection.
RESULTS

High-Dimensional Phenotypic Analyses Revealed an Accumulation of Activated CXCR5 − CD4 + T Cells in HIV-Infected LNs
T cell activation in chronic HIV infection predicts increased mortality in severe disease (Giorgi et al., 1999) . To better understand the heterogeneity of activated T cells in the LN, we performed mass cytometry with a 36-marker panel using LNs from eight virally active HIV + patients. Cryopreserved LN cells were stimulated with phorbol-12-myristate-13acetate (PMA) and ionomycin in the presence of brefeldin A and monensin for 5 h, stained with metal-conjugated antibodies, and analyzed on the mass cytometer, cytometry by time of flight 2 (CyTOF2). Data normalization was performed using a bead-based standards to minimize variations due to batch and machine performance (Finck et al., 2013) . We defined activated T cells by CD38 and HLA-DR expression and compared double-positive T cells to quiescent CD38 − HLA-DR − CD3 + T cells ( Figure 1A ). Activated or quiescent CD3 + T cells were further divided into CD4 + αβ, CD8 + αβ, or γδ T cells. The majority of CD3 + cells expressed αβ TCRs, mostly CD4 + in the CD38 − HLA-DR − subset but predominantly CD8 + in the CD38 + HLA-DR + subset ( Figure 1A ). Activated T cells were enriched in memory and effector molecules, whereas markers indicative of a less differentiated state, TCF1 and CCR7, were more highly expressed in quiescent T cells ( Figure 1B) . Although activated T cells contained a lower relative frequency of CD4 + T cells, CD38 + HLA-DR + CD4 + T cells were more abundant in patients with more severe HIV infection ( Figure S1A ).
To further examine CD4 + T cells for activation-associated changes relevant to HIV infection, equal numbers of manually gated CD4 + T cells from each donor were combined, and nonlinear dimensional reduction was performed using Uniform Manifold Approximation and Projection (UMAP; Figures S1B-S1C) . We observed a substantial population of Foxp3 + cells and heterogeneous interferon gamma (IFN-γ), interleukin-2 (IL-2), and tumor necrosis factor alpha (TNF-α) expression, but few cells with positive IL-4, IL-13, or IL-17 staining ( Figure S1C ). While CXCR5 and PD-1 co-expression classically defines T FH cells, PD-1 staining covered a broader region on UMAP and included areas with little CXCR5 signal ( Figure 1C ). PD-1 + cells with weak or absent CXCR5 expression were concentrated in areas with higher CD38, ICOS, and Ki67 staining ( Figure S1C ). To better delineate cellular heterogeneity with respect to PD-1 and CXCR5, we subdivided CXCR5 + and CXCR5 − cells by high (++), intermediate (+), or negative (−) PD-1 expression ( Figure  S1D ). The mean intensity of individual markers expressed by each subset was grouped in a heatmap by hierarchical clustering. This separated CD4 + T cells by the level of PD-1 expression, with PD-1 ++ cells staining most strongly for other markers of T cell activation, including CD38, Ki67, CD71, ICOS, and HLA-DR ( Figures 1D and 1E ). To validate the findings above, we performed fluorescent cytometry on a separate set of LN cells from HIV + patients and healthy controls (HCs) and subdivided CD4 + T cells as in the CyTOF dataset ( Figure 1F ). Compared to HCs, CD4 + T cells expressing intermediate or high levels of PD-1 were significantly elevated in HIV-infected LNs ( Figure 1G ). CXCR5 − PD-1 ++ lymphocytes contained a high frequency of CD38 + T cells, which was further increased in the ICOS + subset (ICOS − : 31.5%, ICOS + : 68.2%, Figure 1I ). Our data were consistent with prior work by Perreau et al. (2013) , which also demonstrated an expansion of activated CXCR5 − PD-1 + T cells in HIV-infected LNs. However, the significance of this population within the context of HIV infection remains unclear. Using a previously acquired CyTOF dataset from a larger set of HIV-infected LN samples , we showed that CXCR5 − memory CD4 + T cells with double PD-1 and ICOS expression were associated with more severe HIV infection by low blood CD4:CD8 ratio and CD4 + T cell count . Identification of activated PD-1-expressing CXCR5 − T cells by positive CD38 staining revealed similar associations ( Figures S2E-S2G ). Taken together, our data provided a broad overview of T cells in HIV-infected LNs and revealed pathologic accumulation of activated CXCR5 − CD4 + T cell population with high levels of PD-1 expression during chronic HIV infection.
CXCR5 − PD-1 + CD4 + T Cells Express Co-inhibitory Receptors but Retain Cytokine-Producing Potential
PD-1 is a co-inhibitory receptor expressed by T FH cells and up-regulated by exhausted T cells. Thus, we initially hypothesized that PD-1 expression on CXCR5 − T cells marked a population of exhausted CD4 + T cells driven by the depleted CD4 + T cell niche and chronic antigen stimulation by HIV infection. To test this, we stained HIV-infected LN cells for additional co-inhibitory receptors, Lag-3, TIGIT, 2B4, Tim-3, and CD39 (Crawford et al., broadly divided cells into PD-1 − or PD-1 +/++ subsets. This showed TNF-α and/or IFN-γ production by PD-1-expressing T cells following PMA and ionomycin stimulation ( Figure  2B ). To refine this analysis, Boolean gates for IL-2, IFN-γ, and TNF-α were applied onto individual CD4 + subsets to identify all combinations of cytokine production ( Figure S3B ). Compared to the CXCR5 − PD-1 − subset, CXCR5 − PD-1 ++ T cells contained a significantly higher frequency of IFN-γ-producing cells, including single IFN-γ-secreting cells (4.26%); double IFN-γ and TNF-α producers (17.04%); and triple IFN-γ+TNF-α-+IL-2-producing T cells (7.23%, Figures 2C and S3C ). To determine if CXCR5 − PD-1 ++ T cells can also produce IL-21, a critical mediator of B cell selection and differentiation in the LN, we analyzed a previously acquired CyTOF dataset on HIV-infected LNs that included IL-21 staining . This identified IL-21 production in a substantial fraction of memory CD4 + T cells with CXCR5 − PD-1 2++ phenotype (CXCR5 − PD-1 − : 2.90%, CXCR5 − PD-1 ++ : 12.09%, CXCR5 + PD-1 ++ : 8.92%, Figures 2D and S4A ). Staining by flow cytometry also showed IL-21 secretion was not restricted to CXCR5 + T cells (Figures S4B and S4C) . Collectively, these data demonstrated preservation of cytokine-producing potential in a subset of CXCR5 − CD4 + T cells that displayed increased co-inhibitory receptor expression.
CXCR5 − PD-1 + ICOS + T Cells Express T FH -Associated Proteins and Function
The ability to produce IL-21 under stimulation suggested the possibility that the CXCR5 − population may be more similar to T FH cells than exhausted T cells or other types of conventional CD4 + T cells. To evaluate additional T FH -cell-related protein expression, we examined CXCR5 − T cells for upregulation of BCL6, Maf, and CD84. BCL6 and Maf are key transcriptional regulators of T FH cell specification and function (Bauquet et al., 2009; Yu et al., 2009) , whereas CD84 belongs to signaling lymphocyte activation molecule (SLAM) family of receptors that transduces adhesion signals to drive germinal center differentiation (Cannons et al., 2010) . Herein, we included ICOS and CD45RO to more precisely define T FH cells ( Figure S5A ). We also added ICOS to the selection of PD-1expressing CXCR5 − T cells because it enriched for the activation phenotype and identified a subset of CXCR5 − T cells that correlated with more severe HIV infection (Figures 1I and 1J) . PD-1 + ICOS + memory cells were compared to PD-1 − ICOS − memory cells and naive CD4 + T cells. Analyses of BCL6, Maf, and CD84 staining in CXCR5 − PD-1 + ICOS + T cells showed higher expression for all three proteins relative to non-T FH cells but a weaker staining for BCL6 and Maf compared to T FH cells (Figures 3A and S4D) .
To determine if the partial resemblance between CXCR5 − PD-1 + ICOS + T cells and T FH cells extended to a similar functional program, we performed T:B coculture assays to assess the potential for B cell helper function. Naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , and T FH cells were sorted and cultured with autologous B cells at 1:1 ratio and stimulated with Staphylococcal Enterotoxin B (SEB). CXCR5 − PD-1 + ICOS + T cells drove plasma cell differentiation and immunoglobulin G (IgG) production similar to the level observed in T FH cells ( Figures 3B-3D ). Interestingly, B cells cocultured with CXCR5 − PD-1 − ICOS − memory T cells also produced significantly more antibodies compared to naive T cells, at a level comparable to or exceeding that of B cells cocultured with T FH cells in one-third of the samples (5/15). This observation may be a nonspecific feature of the experimental condition or could reflect a broader range of B cell helper activity by other types CD4 + T cells. The ability of CXCR5 − PD-1 − ICOS − T cells to survive and expand better in vitro likely also contributed to this finding ( Figure 3E ).
Next, we examined the in vivo relevance of CXCR5 − PD-1 + ICOS + T cells by measuring correlative changes in B cell differentiation in primary LN samples. In the context of Tolllike receptor (TLR) engagement, IFN-γ has been shown to induce a distinct effector B cell subset characterized by T-bet expression (Barnett et al., 2016; Knox et al., 2017; Rubtsova et al., 2013) . Because CXCR5 − PD-1 ++ T cells exhibited an IFN-γ-dominant functional profile ( Figure 2C ) and produced a higher level of IFN-γ in the supernatant compared to T FH cells ( Figure 3F ), we hypothesized that IFN-γ-producing CXCR5 − PD-1 + ICOS + T cells could promote B cell differentiation toward the T-bet + subset. Using T-bet and CXCR3 coexpression to identify T-bet + B cells, we showed higher T-bet + B cell frequency in HIVinfected LNs compared to cells from HCs, which positively correlated with the frequency of IFN-γ-producing CXCR5 − PD-1 + ICOS + T cells ( Figures 3G and 3H ). Collectively, the in vitro functionality of CXCR5 − PD-1 + ICOS + T cells and the associated B cell changes in primary LNs provide supportive evidence for regulation of B cell responses by CXCR5 − PD-1 + ICOS + T cells during chronic HIV infection.
CXCR5 − PD-1 + ICOS + Subset Contains HIV-Specific T Cells that Drive B Cell Responses In Vitro
Past studies have found an expansion of HIV-specific T FH cells during chronic HIV infection (Lindqvist et al., 2012; Perreau et al., 2013; Wendel et al., 2018) . Given the functional and phenotypic similarity between CXCR5 − PD-1 + ICOS + T cells and T FH cells, next we determined if the CXCR5 − PD-1 + ICOS + subset was also enriched for HIV-specific T cells. We stimulated total LN cells with overlapping pools of Gag peptides for 18 h and identified peptide-specific T cells within naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , or T FH cells by CD25 and OX40 upregulation (Dan et al., 2016) . The frequency of CD25 and OX40 double-positive T cells in DMSO-vehicle-treated backgrounds were subtracted from Gag peptide stimulated cultures to calculate the frequency of Gag-reactive T cells. On average, 1.86% of CXCR5 − PD-1 + ICOS + (0%-4.2%) and 0.83% of T FH cells (0%-3.20%) expressed OX40 and CD25 in response to peptide stimulation, whereas negligible numbers of CD25 + OX40 + cells were detected in the naive and CXCR5 − PD-1 − ICOS − subsets (Figures 4A and 4B) .
To examine the functional activity of HIV-specific T cells within the naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , or T FH cell fraction, sort purified T cell subsets were cultured with B cells and stimulated by Gag and Env peptides. B cell response was absent in naive and CXCR5 − PD-1 − ICOS − T cell cocultures. In contrast, sufficient numbers of CXCR5 − PD-1 + ICOS + and T FH cells responded to HIV peptides to drive plasma cell differentiation and IgG production by B cells, despite a lower overall survival of these cells in culture (Figures 4C-4E; Figure S6A ). Analyses of antibody specificity showed limited recognition of recombinant Gag/Env proteins and no binding to Gag/Env peptides. HIV-specific antibodies accounted for 4% (0%-10%) of total IgG antibodies in the supernatant from T FH cell cocultures and 10% (0%-49%) of the antibodies generated in the presence of CXCR5 − PD-1 + ICOS + T cells (Figures 4F and 4G) . Consistent with this, HIV peptide-stimulated CXCR5 − PD-1 + ICOS + T cells induced antibody secreting cells (ASCs) by enzyme-linked immune absorbent spot assay (ELISPOT), which contained rare, but appreciable, B cell responses against Gag/Env proteins ( Figures S6B-S6D ). Collectively, these data identified HIV-specific T cells within the CXCR5 − PD-1 + ICOS + phenotypic subset and provide evidence for their ability to promote B cell response in vitro.
CXCR5 − PD-1 + ICOS + T Cells Are Clonally Related to T FH Cells and Share a Similar Epigenetic Landscape
The enrichment of T cells reactive to the same antigens suggested the possibility that CXCR5 − PD-1 + ICOS + cells and T FH cells shared overlapping TCR repertoires. We tracked the clonal relationship between CXCR5 − PD-1 + ICOS + T cells and T FH cells by taking advantage of TCR sequence as a unique T cell identifier. T cells expressing the identical TCR sequences are necessarily generated from the same precursors, and thus we can use TCR sequences to infer the relatedness between phenotypically distinct populations. We performed TCR repertoire sequencing on sorted naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , and T FH cells ( Figure S5A ). Common sequences shared between CXCR5 − PD-1 + ICOS + and other T cell subsets were shown as connecting lines on circos plots and quantified by the Bhattacharyya Coefficient as an index of sequence similarity (Bhattacharyya, 1943 ) ( Figure 5A ). Analysis of the combined TCR sequencing data from 9 donors showed that the clonal overlap between CXCR5 − PD-1 + ICOS + T cells and other T cell subsets was highest with T FH cells, which significantly exceeded the repertoire similarities with naive cells or CXCR5 − PD-1 − ICOS − T cells ( Figure 5B ).
The overlap in TCR sequence repertoire between CXCR5 − PD-1 + ICOS + and T FH cells could reflect variable CXCR5 expression between cells along a single differentiation trajectory and/or divergent differentiation from a shared CXCR5 − precursor population. To distinguish between these possibilities, transposase-accessible chromatin with sequencing (ATAC-seq) was performed to provide a glimpse into the differentiation history of CXCR5 − PD-1 + ICOS + T cells. We anticipated CXCR5 − PD-1 + ICOS + T cells to have open chromatin region around CXCR5 promoter region if these cells had previously expressed CXCR5 and remained transcriptionally permissive for CXCR5 expression. Alternatively, we would expect to find a closed CXCR5 promoter region if CXCR5 − PD-1 + ICOS + T cells did not go through a CXCR5 + state or if changes in the chromatin structure were short-lived. We generated a chromatin accessibility map for naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , and T FH cells. Principal-component analysis (PCA) separated naive and CXCR5 − PD-1 − ICOS − T cells from CXCR5 − PD-1 + ICOS + T cells along the first and second principal components (PCs) ( Figure 5C ). Notably, CXCR5 − PD-1 + ICOS + cells and T FH cells occupied overlapping PCA space, indicating highly similar epigenetic landscapes between these cell subsets irrespective of CXCR5 expression. Focusing on CXCR5, we observed an accessible open chromatin state around the CXCR5 promoter region in CXCR5 − PD-1 + ICOS + T cells, suggesting that CXCR5 − PD-1 + ICOS + T cells had previously been CXCR5 + and/or are poised for CXCR5 expression ( Figure 5D ).
Next, we used TCF1 expression to construct a probable progression between CXCR5 positive and negative states. The transcriptional factor TCF1 is expressed at high levels by naive cells and decreases during effector cell differentiation in a cell-cycle-dependent manner (Danilo et al., 2018; Nish et al., 2017) . Compared to T FH cells, approximately twice as many CXCR5 − PD-1 + ICOS + T cells were CD38 + TCF1 − (23.2% versus 11.3%), suggesting that the CXCR5 − PD-1 + ICOS + phenotype enriched for activated T cells in a more differentiated state ( Figures 5E and Figures 5F) . In culture conditions, CXCR5 expression was unstable on T FH cells and became downregulated following SEB-induced T cell stimulation and cell division ( Figures 5G, S4E, and S4F) . These data support a shared differentiation program between CXCR5 − PD-1 + ICOS + T cells and T FH cells and suggest downregulation of CXCR5 as a potential mechanism that contributes to the accumulation of CXCR5 − PD-1 + ICOS + T cells in inflamed LNs.
Transcriptomic Analyses Capture a Unique Set of Gene Signature Expressed by CXCR5 − PD-1 + ICOS + T Cells
To begin to elucidate the functional program of CXCR5 − T cells, we performed transcriptomic profiling of naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , and T FH cells by RNA sequencing (RNA-seq). PCA of the RNA-seq dataset partitioned CXCR5 − PD-1 + ICOS + T cells in a region neighboring T FH cells on the PCA space, indicating considerable similarity in the global transcriptomics between these two populations ( Figure  6A ). To identify gene programs that are unique to CXCR5 − PD-1 + ICOS + T cells, we used gene set enrichment analysis (GSEA) to identify the Gene Ontology (GO) biological pathways enriched in CXCR5 − PD-1 + ICOS + T cells compared to T FH cells. In parallel, we identified 344 genes differentially expressed between CXCR5 − PD-1 + ICOS + T cells and T FH cells using DEseq2. We then used GOrilla to find GO biological pathways enriched by this gene set. The results from GSEA and differential gene expression analyses were combined to identify GO terms common to both analyses methods, which were consolidated by REVIGO to remove redundancy (Supek et al., 2011) ( Figure S7 ). The pathways revealed by these analyses included processes involved in cell migration, T cell activation, and differentiation ( Figure 6B ). Expectedly, the absence of CXCR5 protein expression predicted a low CXCR5 transcripts level in CXCR5 − PD-1 + ICOS + T cells ( Figure 6C ). In addition, CXCR5 − PD-1 + ICOS + T cells showed decreased expression of other T FH -related genes, including BCL6 and its upstream regulator IKZF3 (Read et al., 2017) , as well as key molecules necessary for stable T cell:B cell interaction, SLAM Associated Protein/SH2 Domain Protein 1A (SH2D1A), and CD40LG (Armitage et al., 1992; Qi et al., 2008) . Instead, Th1-associated genes TBX21, RUNX3, and ID2 were elevated in CXCR5 − PD-1 + ICOS + T cells (Djuretic et al., 2007; Shaw et al., 2016; Szabo et al., 2000) . The list of differentially expressed pathways was also notable for migration-related processes. The transcript level of sphingosine-1-phosphate receptor 1 (S1PR1) receptor and its upstream regulator KLF2 were both increased in CXCR5 − PD-1 + ICOS + T cells compared to T FH cells (Skon et al., 2013) . In addition, CXCR5 − PD-1 + ICOS + T cells expressed high levels of genes encoding adhesion molecules, ITGB1 and SELPLG, as well as proinflammatory chemokine receptors that mediate migration to sites of inflammation, including CCR2, CXCR6, CCR5, CCR9, and CCR10. In spite of global transcriptomic similarities between CXCR5 − PD-1 + ICOS + T cells and T FH cells, CXCR5 − PD-1 + ICOS + T cells were more similar to CXCR5 − PD-1 − ICOS − and naive T cells in a targeted analysis of genes encoding trafficking-related receptors and showed the strongest upregulation of CCR5, CXCR6, and CCR2 compared to the other CD4 + T cell subsets ( Figures 6D and S7) . These results indicate that CXCR5 − PD-1 + ICOS + T cells are transcriptionally similar to T FH cells on a global level but differed from T FH cells by the upregulation of genes involved in cellular trafficking and a shifting balance between Th1 and T FH transcriptional programs.
CXCR5 − PD-1 + ICOS + T Cells Express a Migratory Gene Program and Contribute to CXCR5 − PD-1 + ICOS + T Cells in the Peripheral Blood
Because the transcriptional signatures of CXCR5 − PD-1 + ICOS + T cells is dominated by migration-related genes, including the G-protein coupled receptor S1PR1 required for lymphocyte egress (Cyster and Schwab, 2012) , we hypothesized that CXCR5 − PD-1 + ICOS + T cells in the LNs contribute to a circulating pool of CXCR5 − PD-1 + ICOS + T cells in the blood. To test this, we sorted CXCR5 − PD-1 + ICOS + T cells from peripheral blood mononuclear cells (PBMCs) and compared TCR sequences from PBMC and LN cells from the same donors ( Figure S5C ). We hypothesized that we could capture identical TCR sequences in distinct compartments if there is trafficking of cells between blood and LNs. A comparison of the TCR repertoires showed the similarity index were indeed the highest between the TCR repertoires of blood and LN-derived CXCR5 − PD-1 + ICOS + T cells ( Figures 7A and 7B ). In addition, TCRs expressed by circulating CXCR5 − PD-1 + ICOS + T cells also shared a significant overlap with the TCRs expressed by T FH cells in the LN, suggesting a direct or indirect contribution from the T FH cells.
Next, we quantified the frequency of CXCR5 − PD-1 + ICOS + T cells in PBMC and compared it with different T cell subsets in the LN. We found that relatedness by TCR repertoire sequencing predicted shared abundance across compartments. For example, the abundance of circulating CXCR5 − PD-1 + ICOS + T cells correlated with that of CXCR5 − PD-1 + ICOS + T cells and T FH cells in the LN. In contrast, the frequency of CXCR5 − PD-1 + ICOS + T cells in the blood did not correlate with the frequency of lymphoid CXCR5 − PD-1 − ICOS − T cells, with which there was little TCR overlap ( Figure 7C ). The circulating CXCR5 − PD-1 + ICOS + population also showed similar clinical correlation as CXCR5 − PD-1 + ICOS + T cells in the LN and was associated with peripheral CD4 + T cell depletion during chronic HIV infection ( Figure 7D ). Collectively, these data suggest that changes detected in the PBMC were reflective of the related populations in the LN.
To determine if CXCR5 − PD-1 + ICOS + T cells isolated from the PBMC can also modulate B cell responses, naive, CXCR5 − PD-1 − ICOS − , CXCR5 − PD-1 + ICOS + , or CXCR5 + PD-1 + ICOS + (cT FH ) cells were sorted from PBMCs and cocultured with B cells in the presence of SEB. Consistent with past studies, the CXCR5 + subset in the PBMCs provided B cell help (Locci et al., 2013; Morita et al., 2011) (Figures 7E and 7F) . We also found a significantly higher level of antibody production and plasma cell differentiation by B cells in the presence of PBMC-derived CXCR5 − PD-1 + ICOS + T cells. Taken together, these data link CXCR5 − PD-1 + ICOS + T cells in the LN with cells in the blood and suggest that a migratory CXCR5 − T cell population from the LN contribute to the B cell help functionality in the PBMCs.
DISCUSSION
According to the prevailing model of T FH cell differentiation, CXCR5 is expressed in early T FH cells, and it remains expressed during progressive stages of T FH cell differentiation (Crotty, 2014) . CD4 + T cells in the LNs that lacked CXCR5 expression have generally been categorized as non-T FH cells. The focus on CXCR5 as a key T FH cell marker is explained by its critical role in guiding T cells to the B cell zone to promote B cell differentiation and affinity maturation (Arnold et al., 2007; Haynes et al., 2007) . CXCR5 is also the major marker used to identify circulating T FH cells in the blood (Bentebibel et al., 2013; Chevalier et al., 2011; He et al., 2013; Locci et al., 2013; Morita et al., 2011; Vella et al., 2019) . The link between blood and LN-derived CXCR5 + T cells is supported by data from Heit et al., (2017) , which utilized TCR sequencing to demonstrate shared clonal relationship between CXCR5 + PD-1 + T cells in the blood and T FH cells from the tonsils of matched donors. A recent study by Vella et al. (2019) further showed that CXCR5 + T FH cells can traffic into blood via the thoracic duct. By analyzing primary LNs obtained from a cohort of mostly untreated HIV + patients as an effort to understand T cell activation in the lymphoid environment, we provided evidence for an alternative differentiation state that gives rise to a migratory population of T FH -cell-related CXCR5 − T cells during chronic inflammation.
The existence of CXCR5 − CD4 + T cell subset that displayed T FH -cell-like features has been previously described by Perreau et al. (2013) . Using LN cells from HIV-infected patients, Perreau et al. (2013) highlighted T FH cells as a viral reservoir of HIV infection, but intriguingly the same dataset also showed the accumulation of a CXCR5 − PD-1 + population that was enriched for HIV-specific T cells, produced IL-21, and exhibited B cell helper activity in vitro. Our data build on these earlier observations to elucidate the functional relevance of activated CXCR5 − PD-1 + ICOS + T cells and their relationship to other CD4 + T cells within LNs. We had initially hypothesized that CXCR5 − PD-1 + ICOS + T cells in HIVinfected LNs reflected T cell exhaustion from chronic antigen stimulation. While CXCR5 − PD-1 + ICOS + T cells indeed expressed higher levels of co-inhibitory receptors, these T cells retained the ability to produce cytokines, including IL-21. CXCR5 − PD-1 + ICOS + T cells, including those that were HIV specific, also displayed functional capacity to promote plasma cell differentiation and antibody production in vitro. Because CXCR5 − PD-1 + ICOS + T cells exhibited Th1-skewed functional characteristics, we further investigated whether accumulation of CXCR5 − PD-1 + ICOS + T cells in inflamed LNs was associated with an increase in T-bet + B cells. T-bet + B cells mediate effective viral clearance in murine models of chronic infection (Barnett et al., 2016; Rubtsova et al., 2013) . In humans, the contribution of T-bet + B cells to anti-viral protection is less clear, but these B cells accumulate in the PBMCs of HIV-infected individuals and encompass the majority of measurable anti-Env B cell responses during HIV infection (Knox et al., 2017; Moir et al., 2008) . The correlation between the frequencies of T-bet + B cells and IFN-γ-producing CXCR5 − PD-1 + ICOS + T cells in our dataset suggests the possibility that CXCR5 − PD-1 + ICOS + T cells may promote B cell differentiation toward the T-bet + subset, which will require experimental validation in future studies. between CXCR5 − PD-1 + ICOS + T cells and T FH cells and revealed an accessible open chromatin state around CXCR5 promoter region for CXCR5 − PD-1 + ICOS + T cells; second, the TCR repertoire from CXCR5 − PD-1 + ICOS + T cells overlapped with the repertoire of T FH cells, with identical TCR beta chain (TCRβ) complementarity-determining region 3 (CDR3) sequences found in both CXCR5 + and CXCR5 − subsets; and third, CXCR5 expression became downregulated by T cell activation in vitro. The parsimonious explanation for our data is that activation-dependent downregulation of CXCR5 on T FH cells led to the accumulation of CXCR5 − PD-1 + ICOS + T cells. Flexibility in CXCR5 expression is consistent with studies in mice that showed the emergence of a small population of CXCR5 − effectors after lymphocytic choriomeningitis virus (LCMV) infection from adoptively transferred antigen-specific CXCR5 + T cells (Hale et al., 2013) . The open chromatin state around CXCR5 promoter further indicates that CXCR5 − PD-1 + ICOS + T cells remain permissible for CXCR5 expression and suggest the potential for reversibility of CXCR5 expression in CXCR5 − T cells. Our data do not rule out the possibility for the coexistence of additional processes that may be non-T FH -cell related. Differences in the source of precursor cells and/or the chosen differentiation pathway may further contribute to the heterogeneity of phenotypic subsets within CXCR5 − PD-1 + ICOS + T cells, which remains to be fully elucidated.
The LN-derived CXCR5 − CD4 + T cells in our analyses appear phenotypically similar to a recently discovered peripheral CXCR5 − CD4 + T cell population characterized by CCR2 and HLA-DR expression and have the ability to promote B cell responses (Rao et al., 2017) . These cells were found to localize in close proximity to B cells in the synovial lymphoid aggregates of patients with seropositive rheumatoid arthritis and have been suggested to drive ectopic antibody responses in chronically inflamed tissues (Rao et al., 2017) . Another study from Christophersen et al. (2019) identified CXCR5 − PD-1 + gluten-specific T cells in the intestines and blood of patients with celiac disease. Notably, these gluten-specific T cells were enriched for CD38, HLA-DR, ICOS, and CD39 expression, which were also highly expressed by the CXCR5 − PD-1 + ICOS + population in our dataset. As the majority of circulating CXCR5 + cells do not become CXCR5 − in vitro (Rao et al., 2017) , the origin of peripheral CXCR5 − PD-1 + T cells remains unknown. Our data on LN samples linked cells in the lymphoid and peripheral compartments by demonstrating that a population of CXCR5 − PD-1 + ICOS + T cells acquires a migratory program in chronically inflamed LNs. Movement of expanded CXCR5 − PD-1 + ICOS + T cells from the LN into blood could establish a pool of circulating CXCR5 − T cells that are poised for CXCR5 expression. Building on the insights generated by Rao et al. (2017) and Christophersen et al. (2019) , we suggest that these lymphoid-derived circulating CXCR5 − T cells likely infiltrate inflamed tissue sites, and their unique cytokine profile could further modify the quality and the potency of ectopic B cell responses.
In summary, we have uncovered an accumulation of activated CXCR5 − CD4 + T cell subset marked by high PD-1 expression in HIV-infected LNs. Our results linked LN pathology to changes in circulating T cells. As chronic inflammatory state is a shared feature across infection and autoimmunity, the accumulation of CXCR5 − PD-1 + ICOS + T cells in the LN may represent a general state of lymphoid dysregulation that contributes to inflammatory responses in peripheral compartments. IFN-γ, CD69, TNF-α, CD27, CXCR4, CXCR5, CD103, CCR4, CCR6, IL-13, IL-17A, CD38, and HLA-DR. The heatmap was generated using the "gplot" package in R and show the raw staining intensity of each marker after arcsinh transformation. Heatmap dendograms were clustered by Euclidean distance.
Cell sorting and staining by flow cytometry-For surface staining, cells were stained with antibody cocktails for 30 minutes at room temperature. Fixable aqua dye (ThermoFisher) staining was used for live/dead discrimination. T cell stimulation was performed as described above by adding PMA and ionomycin for 5 hours in the presence monensin and Brefeldin A. For intracellular cytokine or transcription factor staining, cells were permeabilized and fixed using Foxp3 staining buffer set and stained in permeabilization buffer according to vendor protocol (eBioscience). Samples were acquired on LSRII (BD Biosciences). For cell sorting, freshly thawed LN cells were separated into ICOS high or ICOS low subset by positive enrichment using a magnetic column (Miltenyi Biotec). See Figure S5 for the gates used for sorting T cells and B cells. Cell sorting was performed using FACSAria III (BD Biosciences). Analyses were performed using FlowJo 10.0.8 (Tree Star).
T:B coculture assays and antigen-specific analyses-Memory B cells (5,000 cells/ well) were cultured with T cells (5,000 cells/well) in a V-bottom plate with media supplemented with the anti-retroviral drugs Raltegravir (1uM, Cayman Chemical) and Efavorez (1uM, Cayman Chemical). For a subset of experiments that examined stability of CXCR5 expression, T FH cells were stained with CFSE (3uM, Invitrogen) after sorting and prior to coculture. Cells were treated with DMSO, SEB (1ug/mL, Toxin Technology), or Gag and Env peptide pools (0.25ug/mL of #12425 and #12540, NIH AIDS Reagent Program). Measurements of IgG level, B and T cell phenotypes were assayed after 7 days in culture. IFN-γ level in the supernatant was measured using Luminex by the Human Immunology Core at the University of Pennsylvania. For detection of HIV-specific T cells, LN cells were incubated with 0.25ug/mL of Gag peptide pools and analyzed for OX40 and CD25 co-expression after 18 hours.
ELISA and ELISPOT assays-ELISA and ELISPOT were performed according to standard protocols with minor modifications (Rouers et al., 2017; Saletti et al., 2013) . Briefly, anti-human IgG (1:100, Bethyl), pooled Gag and Env peptides (5ug/mL, #12425 and #12540 NIH AIDS Reagent Program) or recombinant Gag and Env proteins (0.4ug/mL, #7749, #11784, #12028, #13126, #12577 NIH AIDS Reagent Program) were coated on 96well MaxiSorp-Immuno microplates (Nunc). Plate bound IgG from the culture supernatants or IgG standards (Sigma) were detected using biotinylated anti-IgG (1:2000, BD) , followed by streptavidin-HRP (1:2000, Southern Biotech) and the addition of TMB substrate (Biolegend) for colorimetric readout at OD450 using the Synergy HT plate reader (Biotek). Polyclonal goat antiserum (2:1000, #38 NIH AIDS Reagent Program) was used as positive control for HIV-specificity and detected using anti-Goat Igg-HRP (1:1000, Santa Cruz Biotech). For ELISPOT, 96-well MultiScreenHTS IP Filter plates (Millipore) were coated with goat anti-human kappa/lambda (Southern Biotech), Gag/Env peptide pool (#12425 and #12540, NIH AIDS Reagent Program), or HIV-1 recombinant proteins (#7749, #11784, #12028, #13126, #12577, NIH AIDS Reagent Program) at the final concentration of 5ug/mL in PBS and blocked using RPMI 1640 containing 10% fetal calf serum (FCS). On day 5 of cocultures, B cells from each stimulation condition were equally distributed across PBS or antigen-coated wells and incubated for 6 hours at 37°C. ASC were detected using biotinylated mouse anti-human IgG antibody (1:1000, BD), followed by streptavidin-HRP (1:1000, Southern Biotech). Spots were developed using TMB substrate (Mabtech) and enumerated with an automated Immunospot S6 core analyzer and software (Cellular Technology).
TCRβ sequencing and analyses-TCR library generation and sequencing on FACSsorted T cells was performed as previously described . Briefly, FACSsorted cells were lysed, and total RNA was purified using AllPrep DNA/RNA Micro Kit (QIAGEN). 30% of the purified RNA was used for library generation and sequencing. Consensus sequences were constructed within each molecular identifier (MID) group . Consensus TCR sequences were subjected to the CDR3 blast module of MIGEC (Shugay et al., 2014) to assign V and J alleles and parse out the CDR3 sequence. Bhattacharyya coefficient was used to measure TCR repertoire similarity between CXCR5 − PD-1 + ICOS + T cells with other populations within LN and between CXCR5 − PD-1 + ICOS + T cells in the PBMC and LN subsets (Bhattacharyya, 1943) . Circos plots were generated using circlize R package to visualize clones shared between T cell subsets.
ATAC-seq and analyses-ATAC-seq was performed as previously described with minor modifications (Buenrostro et al., 2013) . In brief, sorted T cells were pelleted and resuspended in 50uL lysis buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl,3 mM MgCl2, 0.1% IGEPAL CA-630). Transposition reaction was carried out immediately in a 25uL reaction with 1.25uL of Tn5 transposase (Illumina) in a 37°C water bath for 37 minutes to tag and fragment accessible chromatin. Tagmented DNA was purified using a MinElute Reaction Cleanup Kit (QIAGEN) and amplified with 12 cycles of PCR. Libraries were purified using Agencourt AMPure XP kit (Axygen). Sample quality was determined using a Tapestation 2200 system (Agilent). Library concentrations were determined using Qubit dsDNA HS Assay Kit (Invitrogen). Libraries were paired-end sequenced on a NextSeq 550 (Illumina). All the reads are quality-trimmed with trimmomatic-0.36-5 (see Table S3 ). The paired-end reads were aligned to human assembly hg19 using bowtie alignment tool (bowtie2-2.3.4.1). The peaks were called using callpeaks function in MACS2. Peaks called with a q-value cutoff of 0.05 (Benjamin-Hochberg correction) were analyzed with DiffBind R package. The intervals for peak comparison were re-centered around the most enriched points with a 500-bp window. The consensus peaksets were then normalized and used as input for differential analysis by DESeq2 with a significance cutoff FDR at 0.05 (Benjamin-Hochberg correction). DiffBind was used to generate the PCA plot.
was performed using the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech). cDNA qualities were determined by a Tapestation 2200 system (Agilent) and concentrations were determined using Qubit dsDNA HS Assay Kit (Invitrogen). DNA libraries were prepared using Nextera XT Library Prep Kit (Illumina) and sequenced on NextSeq 550 (Illumina). All the reads are quality-trimmed with trimmomatic-0.36-5. The paired-end reads were aligned to human assembly hg19 using STAR alignment tool (STAR 2.6). For finding differential expressed genes between samples, DESeq2 R packaged was used to calculate variation, with a significance cutoff padj at 0.05 (Benjamin-Hochberg correction). PCA analysis was performed using plotPCA function in DESeq2 R package. The variant genes were then submitted to GOrilla for gene ontology analysis. Gene Set Enrichment Analysis (GSEA) was performed to compare the enriched genes in CXCR5 + PD-1 + / CXCR5 − PD-1 + T cells. The significant hit from GSEA and Gorilla were matched to generate a list of enriched gene ontologies consistently identified by both methods. The GO list was then revised by removing redundant terms with REVIGO (Supek et al., 2011) , shortening the list from 25 to 8. Scaled normalized expression values were used as input for generating supervised hierarchical clustering heatmap for differentially expressed genes that contributed to the GO terms and for generating the volcano plot.
QUANTIFICATION AND STATISTICAL ANALYSIS
Assessment of normality was performed using D'Agostino-Pearson test. Pearson or Spearman correlation was used depending on the normality of the data to measure the degree of association. The best-fitting line was calculated using least-squares fit regression. Statistical comparisons were performed using two-tailed Student's t test, Mann-Whitney U test, or Wilcoxon signed-rank test, using a p value of < 0.05 as a cutoff to determine statistical significance. Multiple-way comparisons were performed using ANOVA or nonparametric tests (Friedman test for matched measures or Kruskal-Wallis test for unmatched measures). Statistical analyses were performed using GraphPad Prism. Lines and bars represent mean, variability is represented by standard error of the mean (SEM). * p < 0.05; ** p < 0.005; *** p < 0.0005. **** p < 0.0005.
DATA AND CODE AVAILABILITY
The data for this study have been deposited in the database dbGAP under accession number phs001548.v1.p1 (dbGAP: phs001548.v1.p1).
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Highlights
•
High-dimensional profiling of CD4 + T cells in HIV-infected lymph nodes Friedman test was performed and corrected using Dunn's multiple comparisons test. Data are represented as mean ± SEM. Also see Figure S6 . 
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